Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay

Kintor Pharmaceutical, Press Release, Jul 2021
News release announcing that proxalutamide has been granted an emergency use authorization for COVID-19 in Paraguay.
Kintor et al., 16 Jul 2021, preprint, 1 author.